Severity
Moderate
FDA Drug recall · Reported November 13, 2024
Crystallization
Viona Pharmaceuticals INC recalled Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmeda… - a moderate-severity action.
Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmeda… was recalled by Viona Pharmaceuticals INC in November 13, 2024. Reason: Crystallization. Check the official notice for the remedy. Verify recall #D-0038-2025 with the FDA Drug before acting.
The recall
Viona Pharmaceuticals INC issued this moderate-severity FDA Drug recall-Crystallization.
Sourced from official FDA Drug enforcement records. Verify recall #D-0038-2025 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0038-2025) was formally reported on November 13, 2024, with the manufacturer initiating the action on October 29, 2024. It is classified under Moderate severity (Class II), with a current status of Ongoing. Viona Pharmaceuticals INC is listed as the recalling firm, operating out of Cranford, NJ. Federal records list the affected scope as 6048 pumps.
The documented reason for this recall is: Crystallization Distribution data in the federal record shows the product reached: USA Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
6048 pumps
Related Recalls
6
0 from same agency
Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.
Crystallization
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | D-0038-2025 |
| Date reported | November 13, 2024 |
| Date initiated | October 29, 2024 |
| Recalling firm | Viona Pharmaceuticals INC |
| Firm location | Cranford, NJ |
| Affected scope | 6048 pumps |
| Distribution | USA Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported November 13, 2024. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.